Literature DB >> 18044551

Precision targeting of liver lesions with a needle-based soft tissue navigation system.

L Maier-Hein1, F Pianka, A Seitel, S A Müller, A Tekbas, M Seitel, I Wolf, B M Schmied, H P Meinzer.   

Abstract

In this study, we assessed the targeting precision of a previously reported needle-based soft tissue navigation system. For this purpose, we implanted 10 2-ml agar nodules into three pig livers as tumor models, and two of the authors used the navigation system to target the center of gravity of each nodule. In order to obtain a realistic setting, we mounted the livers onto a respiratory liver motion simulator that models the human body. For each targeting procedure, we simulated the liver biopsy workflow, consisting of four steps: preparation, trajectory planning, registration, and navigation. The lesions were successfully hit in all 20 trials. The final distance between the applicator tip and the center of gravity of the lesion was determined from control computed tomography (CT) scans and was 3.5 +/- 1.1 mm on average. Robust targeting precision of this order of magnitude would significantly improve the clinical treatment standard for various CT-guided minimally invasive interventions in the liver.

Entities:  

Mesh:

Year:  2007        PMID: 18044551     DOI: 10.1007/978-3-540-75759-7_6

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  3 in total

1.  Image-based guidance of percutaneous abdomen intervention based on markers for semi-automatic rigid registration.

Authors:  Dominik Spinczyk
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-09-05       Impact factor: 1.195

2.  Ultrasound-based tumor movement compensation during navigated laparoscopic liver interventions.

Authors:  Osama Shahin; Armin Beširević; Markus Kleemann; Alexander Schlaefer
Journal:  Surg Endosc       Date:  2014-01-03       Impact factor: 4.584

Review 3.  Interventional navigation systems for treatment of unresectable liver tumor.

Authors:  Soo Jay Phee; Kai Yang
Journal:  Med Biol Eng Comput       Date:  2009-12-30       Impact factor: 2.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.